4243.T
The company operates in the Commodity Chemicals industry, producing and selling chemical products, primarily generating revenue through the sale of these goods to industrial and manufacturing customers.
Business. The company operates in the Commodity Chemicals industry, producing and selling chemical products, primarily generating revenue through the sale of these goods to industrial and manufacturing customers.
At a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
The company operates in the Commodity Chemicals industry, producing and selling chemical products, primarily generating revenue through the sale of these goods to industrial and manufacturing customers.
The company maintains a strong liquidity position, with cash and equivalents amounting to ¥21.1 billion, significantly exceeding its total liabilities of ¥1.52 billion, resulting in a current ratio of 4.21. Its price-to-book ratio of 0.48 suggests the market values the company at a discount to its book value, while the price-to-tangible-book ratio is similarly low at 0.48. The company's debt-to-equity ratio is 0.05, indicating a conservative capital structure with minimal leverage.
Profitability metrics show a return on equity (ROE) of 4.34% and a return on assets (ROA) of 3.24%, both below the typical thresholds for high-performing chemical firms. The operating margin, calculated as operating income of ¥213.37 million divided by revenue of ¥4.4 billion, is 4.85%, which is in line with the industry median for commodity chemicals. However, the net margin of 4.41% is slightly below the median, suggesting some inefficiencies in cost management or pricing power.
The company's revenue is concentrated in a single business segment, with no disclosed geographic diversification. This lack of diversification increases exposure to regional economic fluctuations and regulatory changes. The company's primary market is Japan, and its performance is closely tied to domestic demand for chemical products.
Looking ahead, the company is projected to maintain stable revenue growth, with a modest increase expected in the next fiscal year. Capital expenditures are currently negative at ¥180.89 million, indicating a reduction in investment in new projects or facilities. This may signal a focus on cost containment or a strategic shift in capital allocation.
The company's risk profile is characterized by low liquidity and dilution risks, with no immediate filing-based flags detected. The low dilution risk is supported by the absence of recent share issuance or shelf registration activity. However, the company's low price-to-book ratio and high cash reserves may attract activist investors, potentially leading to future dilution if new capital is raised.
Recent events include the publication of the latest financial results, which showed a net income of ¥194.09 million. The company has not disclosed any major strategic initiatives or new product launches in the most recent filings. Analysts have noted the company's stable earnings and revenue performance, with the last actual EPS reported at ¥83.56.
- The company has a strong liquidity position with a current ratio of 4.21 and significant cash reserves.
- Profitability metrics are below the industry median, with ROE and ROA at 4.34% and 3.24%, respectively.
- Revenue is concentrated in a single business segment with no geographic diversification.
- The company is projected to maintain stable revenue growth with minimal capital expenditures.
- Low liquidity and dilution risks are reported, with no immediate filing-based flags detected.
Bull / Bear case
analysis pipelineIn focus — financials by report
Valuation
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
Options
Short squeeze
Earnings-call key lines
Estimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- No immediate filing-based liquidity or dilution flags were detected.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Ev To Operating Cash Flowenterprise_value / operating_cash_flow
- Return On Equitynet_income / total_equity
- Price To Earningsmarket_price / (net_income / shares_outstanding_diluted)
- Price To Bookmarket_price / (adjusted_book_value / shares_outstanding_diluted)
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Market Priceinput from market-data provider (delayed close or quote-shim mid)
- 4243.T Market data — financials · 2026-05-26
- Nix Inc Market data — analyst estimates · 2026-05-26